RhumbLine Advisers’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,401	Closed	-$20K	–	4184
2025 Q1	$20K	Sell	16,401 -1,129	-6%	-$1.58K	﹤0.01%	3738
2024 Q4	$22.6K	Buy	17,530 +120	+0.7%	+$288	﹤0.01%	3788
2024 Q3	$47.9K	Sell	17,410 -1,865	-10%	-$4.58K	﹤0.01%	3686
2024 Q2	$43.6K	Buy	+19,275	New	+$58.6K	﹤0.01%	3718
2021 Q2	–	Sell	-30,689	Closed	-$67K	–	3036
2021 Q1	$67K	Buy	30,689 +2,425	+9%	+$5.43K	﹤0.01%	2966
2020 Q4	$63K	Buy	28,264 +2,830	+11%	+$7.43K	﹤0.01%	3011
2020 Q3	$68K	Sell	25,434 -6,365	-20%	-$17.8K	﹤0.01%	2931
2020 Q2	$97K	Buy	31,799 +1,001	+3%	+$2.52K	﹤0.01%	2974
2020 Q1	$60K	Hold	30,798	–	–	﹤0.01%	2843
2019 Q4	$88K	Buy	30,798 +3,468	+13%	+$12.1K	﹤0.01%	2883
2019 Q3	$100K	Buy	27,330 +75	+0.3%	+$271	﹤0.01%	2885
2019 Q2	$113K	Buy	+27,255	New	+$118K	﹤0.01%	2911
2015 Q2	–	Sell	-17,755	Closed	-$59K	–	3046
2015 Q1	$59K	Buy	17,755 +3,400	+24%	+$12.1K	﹤0.01%	2990
2014 Q4	$50K	Buy	14,355 +425	+3%	+$1.88K	﹤0.01%	2992
2014 Q3	$70K	Hold	13,930	–	–	﹤0.01%	2951
2014 Q2	$192K	Buy	+13,930	New	+$173K	﹤0.01%	2853